Other Viruses Citation List:

September 2 - September 15, 2011

Hepatitis B virus

1. Synthesis and Antiviral Activities of Geldanamycin Analog TC-GM in Vitro. Li, C.X., G.Z. Shan, B. Fan, P.Z. Tao, L.X. Zhao, J.D. Jiang, Y.H. Li, and Z.R. Li. Yao xue xue bao. Acta Pharmaceutica Sinica, 2011. 46(6): p. 683-687; PMID[21882529].

[PubMed]. OV_0902-091511.

2. Anti-Hepatitis B Virus and Cytotoxic Diterpenoids from Isodon lophanthoides var. gerardianus. Yang, L.B., L. Li, S.X. Huang, J.X. Pu, Y. Zhao, Y.B. Ma, J.J. Chen, C.H. Leng, Z.M. Tao, and H.D. Sun. Chemical & Pharmaceutical Bulletin, 2011. 59(9): p. 1102-5; PMID[21881252].

[PubMed]. OV_0902-091511.

Hepatitis C virus

3. Synthesis and SAR Optimization of Diketo acid Pharmacophore for HCV NS5B Polymerase Inhibition. Bhatt, A., K.R. Gurukumar, A. Basu, M.R. Patel, N. Kaushik-Basu, and T.T. Talele. European Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21893371].

[PubMed]. OV_0902-091511.

4. Griffithsin has Antiviral Activity against Hepatitis C Virus. Meuleman, P., A. Albecka, S. Belouzard, K. Vercauteren, L. Verhoye, C. Wychowski, G. Leroux-Roels, K.E. Palmer, and J. Dubuisson. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21896910].

[PubMed]. OV_0902-091511.

5. Synthesis and in Vitro Activity of Novel N-3 Acylated TSAO-T Compounds against HIV-1 and HCV. Moura, M., S. Josse, A.N. Van Nhien, C. Fournier, G. Duverlie, S. Castelain, E. Soriano, J. Marco-Contelles, J. Balzarini, and D. Postel. European Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21880398].

[PubMed]. OV_0902-091511.

HCMV

6. An Artemisinin-derived Dimer has Highly Potent Anti-cytomegalovirus (CMV) and Anti-cancer Activities. He, R., B.T. Mott, A.S. Rosenthal, D.T. Genna, G.H. Posner, and R. Arav-Boger. Plos One, 2011. 6(8): p. e24334; PMID[21904628].

[PubMed]. OV_0902-091511.

HSV-1

7. Effects of Ilex paraguariensis A. St. Hil. (Yerba Mate) on Herpes Simplex Virus Types 1 and 2 Replication. Luckemeyer, D.D., V.D. Muller, M.I. Moritz, P.H. Stoco, E.P. Schenkel, C.R. Barardi, F.H. Reginatto, and C.M. Simoes. Phytotherapy Research : PTR, 2011. [Epub ahead of print]; PMID[21915933].

[PubMed]. OV_0902-091511.

8. Antiviral Activity of Distictella elongata (Vahl) Urb. (Bignoniaceae), a Potentially Useful Source of Anti-dengue Drugs from the State of Minas Gerais, Brazil. Simoes, L.R., G.M. Maciel, G.C. Brandao, E.G. Kroon, R.O. Castilho, and A.B. Oliveira. Letters in applied microbiology, 2011. [Epub ahead of print]; PMID[21895729].

PubMed]. OV_0902-091511.

Citations from the ISI Web of Knowledge Listings for O.V.

9. Novel HCV NS5B Polymerase Inhibitors: Discovery of Indole 2-carboxylic acids with C3-Heterocycles. Anilkumar, G.N., C.A. Lesburg, O. Selyutin, S.B. Rosenblum, Q.B. Zeng, Y.H. Jiang, T.Y. Chan, H.Y. Pu, H. Vaccaro, L. Wang, F. Bennett, K.X. Chen, J. Duca, S. Gavalas, Y.H. Huang, P. Pinto, M. Sannigrahi, F. Velazquez, S. Venkatraman, B. Vibulbhan, S. Agrawal, N. Butkiewicz, B. Feld, E. Ferrari, Z.Q. He, C.K. Jiang, R.E. Palermo, P. McMonagle, H.C. Huang, N.Y. Shih, G. Njoroge, and J.A. Kozlowski. Bioorganic & Medicinal Chemistry Letters, 2011. 21(18): p. 5336-5341; ISI[000294051800044].

[WOS]. OV_0902-091511.

10. Swerilactones L-O, Secoiridoids with C(12) and C(13) Skeletons from Swertia mileensis. Geng, C.A., X.M. Zhang, Y.B. Ma, J. Luo, and J.J. Chen. Journal of Natural Products, 2011. 74(8): p. 1822-1825; ISI[000294242800022].

[WOS]. OV_0902-091511.

11. Discovery of Naturally Occurring Aurones That Are Potent Allosteric Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase. Haudecoeur, R., A. Ahmed-Belkacem, W. Yi, A. Fortune, R. Brillet, C. Belle, E. Nicolle, C. Pallier, J.M. Pawlotsky, and A. Boumendjel. Journal of Medicinal Chemistry, 2011. 54(15): p. 5395-5402; ISI[000293419400011]. [WOS]. OV_0902-091511.

12. Quinoxalin-2(1H)-One Derivatives As Inhibitors Against Hepatitis C Virus. Liu, R., Z.H. Huang, M.G. Murray, X.Y. Guo, and G. Liu. Journal of medicinal chemistry, 2011. 54(16): p. 5747-5768; ISI[000294077300010]. [WOS]. OV_0902-091511.

13. DDX60, a DEXD/H Box Helicase, Is a Novel Antiviral Factor Promoting RIG-I-Like Receptor-Mediated Signaling. Miyashita, M., H. Oshiumi, M. Matsumoto, and T. Seya. Molecular and Cellular Biology, 2011. 31(18): p. 3802-3819; ISI[000294246700012]. [WOS]. OV_0902-091511.

14. Inhibition of the Helicase Activity of the HCV NS3 Protein by Symmetrical Dimeric bis-Benzimidazoles. Tunitskaya, V.L., A.V. Mukovnya, A.A. Ivanov, A.V. Gromyko, A.V. Ivanov, S.A. Streltsov, A.L. Zhuze, and S.N. Kochetkov. Bioorganic & Medicinal Chemistry Letters, 2011. 21(18): p. 5331-5335; ISI[000294051800043].

[WOS]. OV_0902-091511.